]>
IRCT20210314050698N1 IRCT 2021-04-03 Ahvaz University of Medical Sciences Effect of vitamin D treatment on magnesium levels in hemodialysis patients Effect of vitamin D treatment on magnesium levels in chronic hemodialysis patients 2021-04-21 anticipated 60 Complete https://irct.ir/trial/55159 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Patients will be assigned into two groups by simple randomization method. Allocation of patients to the study groups will be done by random-numbers table and using computer, and on this basis patients will be included in one of the two treatment groups. The implementation of the random allocation sequence occurs without knowledge of which patient will receive which treatment, Blinding description: Intervention (receiving oral Calcium with D3 500 mg Tabs or Pearl Vit D3-50000) and patient evaluation will be carried out by a physician who is blinded to placement in treatment groups. Also patients and statistical analyzer will not know about patient grouping. 3 Chronic hemodialysis patients. Intervention 1: Intervention group: In this group, oral Pearl Vit D3-50000 unit per week (Dana Pharma CO., Iran) will be prescribed for 3 months. Intervention 2: Intervention group: In this group, Calcium with D3 500 mg tablets (Dineh CO., Iran) every 12 hours will be prescribed for 3 months. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.
public Ebrahim Hamreh
Ahvaz Jundishapur University of Medical Sciences, Golestan Blvd.
Ahvaz Iran (Islamic Republic of) 6135733118 +98 61 5222 2621 ehamreh1366@gmail.com Ahvaz University of Medical Sciences scientific Ebrahim Hamreh
Ahvaz Jundishapur University of Medical Sciences, Golestan Blvd.
Ahvaz Iran (Islamic Republic of) 6135733118 +98 61 5222 2621 ehamreh1366@gmail.com Ahvaz University of Medical Sciences Iran (Islamic Republic of) Age more than 18 years Hemodialysis patients who have been on dialysis for at least three months Vitamin D level less than 30 ng/mL Consent to participate in the study 18 years no limit Both Any active or chronic infection Magnesium supplementation Chronic diarrhea Hyperparathyroidism N18 Chronic kidney disease (CKD) Prevention N/A Intervention group: In this group, oral Pearl Vit D3-50000 unit per week (Dana Pharma CO., Iran) will be prescribed for 3 months. Intervention group: In this group, Calcium with D3 500 mg tablets (Dineh CO., Iran) every 12 hours will be prescribed for 3 months. Serum magnesium level. Timepoint: Before and after treatment (three months later). Method of measurement: Based on laboratory results measured by magnesium kit (Pars Azmoon,Iran). Serum vitD (25-OH-VitD) level. Timepoint: Before and after treatment (three months later). Method of measurement: Based on laboratory results measured by Vit D kit (Monobind,Iran). Ahvaz University of Medical Sciences Approved 2021-03-14 Ethics committee of Ahvaz Jundishapur University of Medical Sciences Ahvaz Jundishapur University of Medical Sciences, Golestan Blvd. Ahvaz Khouzestan Iran (Islamic Republic of)